NCT05273073View on ClinicalTrials.gov

Effects of Probiotics on Gut Microbiota Composition and Metabolic Outcomes in Post- Gestational Diabetes Women

NACompletedINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

April 11, 2021

Study Completion Date

April 26, 2021

Conditions
Gestational Diabetes
Interventions
DIETARY_SUPPLEMENT

Probiotics

Each sachet consists of 30 billion colony-forming units (CFU) of six viable probiotic strains (Lactobacillus acidophilus BCMC® 12130 (107 mg), Lactobacillus casei subsp. BCMC® 12313 (107 mg), Lactobacillus lactis BCMC® 12451 (107 mg), Bifidobacterium bifidum BCMC® 02290 (107 mg), Bifidobacterium infantis BCMC® 02129 (107 mg), and Bifidobacterium longum BCMC® 02120 (107 mg).

DIETARY_SUPPLEMENT

Placebo

Placebo samples were identical to the probiotics in term of taste and texture without live microbial cells.

Trial Locations (1)

56000

Universiti Kebangsaan Malaysia, Cheras

All Listed Sponsors
collaborator

B-Crobes Laboratory (M) Sdn Bhd

UNKNOWN

collaborator

Ministry of Higher Education, Malaysia

OTHER

lead

National University of Malaysia

OTHER

NCT05273073 - Effects of Probiotics on Gut Microbiota Composition and Metabolic Outcomes in Post- Gestational Diabetes Women | Biotech Hunter | Biotech Hunter